Birmingham, West Midlands -- (SBWIRE) -- 12/05/2013 -- Value Penny Stocks issues special report on Vishay Intertechnology (NYSE:VSH), TriQuint Semiconductor (NASDAQ:TQNT), Keryx Biopharmaceuticals (NASDAQ:KERX).
Vishay Intertechnology (NYSE:VSH) ended its recent business day with the loss of -0.88% and closed at the price of $12.34 after opening at $12.37. The stock traded during its last trading session with the total volume of 2,099,282 shares, as compared to its average volume of 1.08 million shares. Vishay Intertechnology Inc. designs, manufactures, and supplies discrete semiconductors and passive components. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors.
Has VSH Found The Bottom and Ready To Move Up? Find Out Here
TriQuint Semiconductor (NASDAQ:TQNT) traded with volume of 2,092,456 shares in the last session, as compared to average volume of 3.20 million shares. In comparison with 52 week range of $4.31 - $8.98, it faced lowest price of $8.01 during the last trading session whereas its day highest price was $8.25. The company’s total market capitalization is $1.30 billion, along with 160.61 million shares outstanding. TriQuint Semiconductor, Inc. provides radio frequency (RF) solutions and technology for mobile device, network infrastructure, and defense and aerospace markets worldwide. The company designs, develops, and manufactures an array of filtering, switching, and amplification products for RF, microwave, and millimeter-wave applications.
Can TQNT Show a Strong Recovery? Find out in This Research Report
Keryx Biopharmaceuticals (NASDAQ:KERX) showed 2,060,434 shares in volume during the last trading session, while the average trading volume remained 3.08 million shares. The stock kicked off its trading session at $14.42 and closed at $14.68 after mounting 1.45%. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Will KERX Continue To Move Higher? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)